StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1035
This month
17
This week
4
This year
110
Today
1
Yesterday
3
Publishing Date
2024 - 04 - 23
2
2024 - 04 - 17
2
2024 - 04 - 16
2
2024 - 04 - 15
2
2024 - 04 - 01
2
2024 - 03 - 29
1
2024 - 03 - 28
3
2024 - 03 - 27
3
2024 - 03 - 25
2
2024 - 03 - 22
2
2024 - 03 - 21
1
2024 - 03 - 20
1
2024 - 03 - 15
1
2024 - 03 - 14
1
2024 - 03 - 13
3
2024 - 03 - 12
1
2024 - 03 - 07
2
2024 - 03 - 06
1
2024 - 03 - 05
2
2024 - 03 - 04
1
2024 - 02 - 29
1
2024 - 02 - 28
2
2024 - 02 - 27
1
2024 - 02 - 25
1
2024 - 02 - 23
1
2024 - 02 - 22
2
2024 - 02 - 21
1
2024 - 02 - 20
1
2024 - 02 - 19
1
2024 - 02 - 16
1
2024 - 02 - 15
1
2024 - 02 - 14
2
2024 - 02 - 13
1
2024 - 02 - 12
3
2024 - 02 - 09
1
2024 - 02 - 08
1
2024 - 02 - 07
1
2024 - 02 - 06
2
2024 - 02 - 05
1
2024 - 02 - 02
3
2024 - 02 - 01
3
2024 - 01 - 31
2
2024 - 01 - 30
2
2024 - 01 - 29
1
2024 - 01 - 26
3
2024 - 01 - 25
3
2024 - 01 - 24
2
2024 - 01 - 23
3
2024 - 01 - 22
1
2024 - 01 - 19
1
2024 - 01 - 17
5
2024 - 01 - 16
2
2024 - 01 - 15
1
2024 - 01 - 12
2
2024 - 01 - 11
1
2024 - 01 - 09
3
2024 - 01 - 08
1
2024 - 01 - 05
2
2024 - 01 - 04
1
2024 - 01 - 02
1
Sector
Communications
1
Consumer durables
1
Consumer non-durables
3
Distribution services
1
Electronic technology
4
Health services
1
Health technology
110
Manufacturing
19
N/a
15
Process industries
1
Producer manufacturing
2
Technology services
2
Tags
Abbvie
1
Acquire
1
Acquisition
1
Active
1
Advanced
4
Agreement
2
America
8
Antibacterial
1
Antibody
3
Application
1
Approved
1
Asia
1
Astrazeneca
2
Biosimilar
2
Business
3
Cancer
8
Cell
3
Diabetes
2
Diagnostics
2
Disease
4
Drug
11
Expansion
4
Expected
3
Fabhalta
2
Financial
4
First
2
For
4
Global
33
Growing
2
Growth
27
Infection
3
Insulin
2
International
2
Key
9
Leukemia
3
Lung
2
Lutathera
2
Market
72
Medical
3
Million
3
Momentum
2
N/a
107
Novartis
14
Pipeline
3
Positive
3
Reach
9
Report
27
Research
15
Respiratory
2
Results
4
Sales
2
Set
7
Show
3
Therapeutics
15
Therapy
7
Transdermal
2
Treatment
7
Tumors
2
Update
2
Year
5
Entities
3m company
1
Abbott laboratories
13
Abbvie inc.
32
Abcam plc
1
Accenture plc
1
Advantest corp
1
Alcon inc.
4
Alkermes plc
1
Alphabet inc.
1
Amgen inc.
22
Anika therapeutics inc.
1
Apple inc.
1
Aquestive therapeutics, inc.
1
Aravive, inc.
1
Argenx se
1
Astellas pharma inc
10
Astrazeneca plc
22
Autolus therapeutics plc
3
Aveo pharmaceuticals, inc.
2
Bausch health companies inc.
4
Baxter international inc.
3
Bio-rad laboratories, inc.
1
Biogen inc.
3
Biomarin pharmaceutical inc.
2
Biontech se
1
Bluebird bio, inc.
1
Brainsway ltd.
1
Bristol-myers squibb company
13
Canon inc
2
Cardinal health, inc.
1
Caribou biosciences inc
1
Eli lilly and company
16
Endo international plc
2
Erasca inc
2
Genmab a/s
2
Gilead sciences, inc.
5
Glaxosmithkline plc
25
Incyte corporation
2
Jazz pharmaceuticals plc
4
Johnson & johnson
22
Koninklijke philips n.v.
4
Lantheus holdings, inc.
2
Mallinckrodt plc
3
Medies
2
Morphosys ag
5
Novartis ag
110
Pfizer, inc.
4
Precision biosciences, inc.
2
Reckitt benckiser group plc
2
Regeneron pharmaceuticals, inc.
2
Regenxbio inc.
2
Sanofi
38
Takeda pharmaceutical company limited
6
Teva pharmaceutical industries ltd
20
Tg therapeutics, inc.
2
Thermo fisher scientific inc
7
Ucb s.a.
2
Verona pharma plc
2
Vertex pharmaceuticals incorporated
3
Viatris inc.
15
Symbols
AAPL
87
ABB
109
ABBNY
109
ABBV
106
ABLZF
109
ABT
213
ADM
81
AMLX
77
AMSIY
81
AMSYF
81
ARCXF
81
ARVL
446
ASRT
74
BNPQF
122
BNPQY
122
BNTX
83
BTI
76
CMI
117
CPT
249
CSCO
84
DADA
84
EAF
77
ERIC
148
FLNT
88
FNCTF
936
GOOG
163
GOOGL
163
HON
152
INMD
85
IRTC
80
JNJ
524
KGS
261
LLY
130
LTRX
75
LTUM
84
MBLY
94
MDT
89
MEDE
139
MS
416
MT
81
NOK
86
NOKBF
101
NVS
113
NVSEF
110
NYCB
88
PB
278
PPRUF
113
PPRUY
113
RILY
83
SAP
91
SAPGF
91
SIF
106
SNOW
75
SNY
474
SNYNF
474
STLA
80
TMO
173
UNTY
99
VZ
133
XYF
99
Exchanges
Nasdaq
110
Nyse
110
Crawled Date
2024 - 04 - 23
2
2024 - 04 - 17
2
2024 - 04 - 16
2
2024 - 04 - 15
2
2024 - 04 - 03
1
2024 - 04 - 01
2
2024 - 03 - 29
1
2024 - 03 - 28
3
2024 - 03 - 27
3
2024 - 03 - 25
2
2024 - 03 - 22
3
2024 - 03 - 20
1
2024 - 03 - 15
1
2024 - 03 - 14
1
2024 - 03 - 13
3
2024 - 03 - 12
1
2024 - 03 - 08
1
2024 - 03 - 07
1
2024 - 03 - 06
1
2024 - 03 - 05
2
2024 - 03 - 04
1
2024 - 02 - 29
1
2024 - 02 - 28
2
2024 - 02 - 27
1
2024 - 02 - 25
1
2024 - 02 - 23
1
2024 - 02 - 22
2
2024 - 02 - 21
1
2024 - 02 - 20
1
2024 - 02 - 19
1
2024 - 02 - 16
1
2024 - 02 - 15
1
2024 - 02 - 14
3
2024 - 02 - 12
3
2024 - 02 - 09
1
2024 - 02 - 08
1
2024 - 02 - 07
2
2024 - 02 - 06
1
2024 - 02 - 05
1
2024 - 02 - 02
3
2024 - 02 - 01
3
2024 - 01 - 31
2
2024 - 01 - 30
2
2024 - 01 - 29
1
2024 - 01 - 26
3
2024 - 01 - 25
3
2024 - 01 - 24
3
2024 - 01 - 23
2
2024 - 01 - 22
1
2024 - 01 - 19
1
2024 - 01 - 17
5
2024 - 01 - 16
2
2024 - 01 - 15
1
2024 - 01 - 12
2
2024 - 01 - 11
1
2024 - 01 - 09
3
2024 - 01 - 08
1
2024 - 01 - 05
2
2024 - 01 - 04
1
2024 - 01 - 02
1
Crawled Time
00:00
5
01:00
3
02:00
3
03:00
7
05:00
8
06:00
5
07:00
3
08:00
2
09:00
5
10:00
4
11:00
7
11:01
1
12:00
6
13:00
1
14:00
3
14:30
2
15:00
1
15:30
3
16:00
3
17:00
5
18:00
10
19:00
1
20:00
5
20:20
2
21:00
1
22:00
7
23:00
7
Source
www.biospace.com
3
www.globenewswire.com
24
www.prnewswire.com
83
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
published :
This year
symbols :
NVSEF
save search
Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria
Published:
2024-04-24
(Crawled : 05:00)
- globenewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
0.0%
|
O:
-0.49%
H:
0.0%
C:
0.0%
malaria
positive
treatment
for
novartis
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
Published:
2024-04-23
(Crawled : 18:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
0.94%
|
O:
1.69%
H:
0.02%
C:
-0.74%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.32%
|
O:
4.32%
H:
0.0%
C:
0.0%
lutathera
fda
first
approved
tumors
for
novartis
therapy
Novartis delivers double-digit sales growth and core margin expansion in Q1; FY 2024 guidance raised
Published:
2024-04-23
(Crawled : 05:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
0.94%
|
O:
1.69%
H:
0.02%
C:
-0.74%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.32%
|
O:
4.32%
H:
0.0%
C:
0.0%
MOR
|
News
|
$18.07
0.17%
0.17%
130K
|
Health Technology
|
0.39%
|
O:
0.39%
H:
0.0%
C:
0.0%
sales
expansion
novartis
growth
Over-The-Counter Drug Market size is set to grow by USD 58.54 billion from 2023-2027, Abbott Laboratories, Achelios Therapeutics Inc. and AstraZeneca Plc, and more to emerge as Some of the Key Vendors, Technavio
Published:
2024-04-22
(Crawled : 22:00)
- prnewswire.com
RBGPF
|
News
|
$52.06
6.46%
4.8K
|
Consumer Non-Durables
|
0.08%
|
O:
0.98%
H:
5.46%
C:
-0.89%
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-3.74%
|
O:
-3.15%
H:
0.0%
C:
-0.61%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
1.13%
|
O:
0.96%
H:
2.38%
C:
0.17%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
0.94%
|
O:
1.69%
H:
0.02%
C:
-0.74%
RBGLY
|
News
|
$10.59
-2.05%
850K
|
Manufacturing
|
1.7%
|
O:
-0.28%
H:
2.18%
C:
1.99%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.32%
|
O:
4.32%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
1.6%
|
O:
0.17%
H:
1.48%
C:
1.43%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
0.49%
|
O:
0.56%
H:
0.41%
C:
-0.07%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
1.7%
|
O:
1.7%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
1.03%
|
O:
0.4%
H:
0.0%
C:
0.0%
drug
astrazeneca
set
key
therapeutics
market
Viral Vector and Plasmid DNA Technologies: A Global Market Perspective
Published:
2024-04-17
(Crawled : 10:00)
- prnewswire.com
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
1.46%
|
O:
-0.26%
H:
0.03%
C:
-1.55%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
6.51%
|
O:
0.87%
H:
0.16%
C:
-0.59%
RGNX
|
$16.05
0.94%
0.93%
350K
|
Health Technology
|
-10.9%
|
O:
-1.43%
H:
2.27%
C:
-3.18%
global
dna
market
Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis
Published:
2024-04-17
(Crawled : 06:00)
- globenewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
6.51%
|
O:
0.87%
H:
0.16%
C:
-0.59%
kesimpta
sclerosis
novartis
show
benefits
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published:
2024-04-16
(Crawled : 14:00)
- prnewswire.com
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
0.35%
|
O:
-0.53%
H:
0.0%
C:
-1.24%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.95%
|
O:
-1.46%
H:
0.0%
C:
0.0%
PHG
|
News
|
$20.97
-0.19%
0.0%
650K
|
Health Technology
|
1.64%
|
O:
-1.21%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
1.83%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
VRNA
|
$15.21
-2.44%
-2.5%
320K
|
Health Technology
|
-1.33%
|
O:
1.65%
H:
2.43%
C:
0.87%
reach
treatment
research
market
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
Published:
2024-04-16
(Crawled : 11:00)
- globenewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.95%
|
O:
-1.46%
H:
0.0%
C:
0.0%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
-0.84%
|
O:
-1.94%
H:
0.43%
C:
-0.34%
OCUL
|
News
|
$4.645
-7.1%
-7.64%
3.9M
|
Health Technology
|
-35.4%
|
O:
-1.03%
H:
3.66%
C:
1.7%
ocular
key
leaders
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published:
2024-04-15
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
1.38%
|
O:
-1.75%
H:
0.85%
C:
0.85%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
3.21%
|
O:
2.1%
H:
0.0%
C:
-2.52%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.95%
|
O:
-1.46%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
1.83%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
BAX
|
$40.93
-0.22%
0.0%
2.2M
|
Health Technology
|
2.45%
|
O:
-0.1%
H:
0.13%
C:
-1.08%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
4.87%
|
O:
0.32%
H:
0.96%
C:
0.22%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
0.41%
|
O:
-2.13%
H:
0.0%
C:
0.0%
BMRN
|
$91.25
-0.88%
-0.89%
1.6M
|
Health Technology
|
0.6%
|
O:
-0.72%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
3.08%
|
O:
-0.64%
H:
0.45%
C:
-0.04%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
3.02%
|
O:
0.41%
H:
0.0%
C:
0.0%
set
therapeutics
market
New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
Published:
2024-04-15
(Crawled : 18:00)
- globenewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.95%
|
O:
-1.46%
H:
0.0%
C:
0.0%
fabhalta
nephropathy
for
novartis
show
Novartis tender offer for MorphoSys AG commences
Published:
2024-04-11
(Crawled : 09:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
2.02%
|
O:
-0.32%
H:
0.48%
C:
-0.17%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.54%
|
O:
0.32%
H:
0.04%
C:
-0.56%
MOR
|
News
|
$18.07
0.17%
0.17%
130K
|
Health Technology
|
0.25%
|
O:
0.69%
H:
0.0%
C:
-0.39%
for
novartis
Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published:
2024-04-10
(Crawled : 09:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-11.83%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-0.01%
|
O:
-0.01%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
0.31%
|
O:
-1.67%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-9.36%
|
O:
-0.29%
H:
0.0%
C:
-1.97%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
-3.07%
|
O:
-0.6%
H:
1.03%
C:
0.52%
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
-4.03%
|
O:
-2.01%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
3.33%
|
O:
-1.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-0.99%
|
O:
-0.32%
H:
0.0%
C:
0.0%
JAZZ
|
$108.38
-1.18%
-1.19%
400K
|
Health Technology
|
-5.16%
|
O:
-1.71%
H:
0.57%
C:
0.37%
disorders
system
set
market
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published:
2024-04-08
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
1.68%
|
O:
2.24%
H:
0.0%
C:
-0.8%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
5.31%
|
O:
-3.43%
H:
6.21%
C:
6.21%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
-3.73%
|
O:
-0.25%
H:
1.1%
C:
-0.17%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
3.2%
|
O:
-0.05%
H:
0.43%
C:
-0.27%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-4.54%
|
O:
-0.08%
H:
0.04%
C:
-0.35%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
-18.06%
|
O:
0.38%
H:
0.0%
C:
-7.27%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
0.96%
|
O:
0.77%
H:
1.63%
C:
0.35%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
0.29%
|
O:
0.84%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
5.04%
|
O:
0.18%
H:
0.3%
C:
0.19%
eczema
dermatitis
set
therapeutics
market
New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting
Published:
2024-04-06
(Crawled : 20:20)
- globenewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
leqvio
novartis
therapy
show
Positron Emission Tomography Market size is set to grow by USD 725.97 mn from 2024-2028,increasing prevalence of chronic conditions worldwide boost the market- Technavio
Published:
2024-04-03
(Crawled : 06:00)
- prnewswire.com
CAJPY
|
$28.73
-0.41%
39K
|
n/a
|
-2.91%
|
O:
-0.3%
H:
0.54%
C:
0.54%
CAJFF
|
$29.0664
-28.15%
760
|
Electronic Technology
|
-2.61%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
1.05%
|
O:
-2.86%
H:
0.17%
C:
0.17%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.71%
|
O:
0.04%
H:
0.46%
C:
-0.08%
PHG
|
News
|
$20.97
-0.19%
0.0%
650K
|
Health Technology
|
5.47%
|
O:
1.0%
H:
0.0%
C:
0.0%
worldwide
set
market
NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
Published:
2024-04-01
(Crawled : 12:00)
- globenewswire.com
NAMS
|
$21.8
1.63%
1.61%
120K
|
n/a
|
-4.26%
|
O:
6.23%
H:
2.77%
C:
-10.21%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
2.57%
|
O:
0.47%
H:
0.23%
C:
-0.99%
pharma
business
Carisma Therapeutics Announces Changes to its Board of Directors
Published:
2024-04-01
(Crawled : 11:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
2.57%
|
O:
0.47%
H:
0.23%
C:
-0.99%
CRIS
|
$14.705
-2.03%
-2.07%
4.7K
|
Health Technology
|
39.3%
|
O:
0.7%
H:
16.87%
C:
16.87%
therapeutics
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
News
|
$28.47
-0.32%
-0.32%
460K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
News
|
$290.34
3.83%
340
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
LASIK Surgery Market size to record USD 1.24 bn growth from 2024-2028, Increasing medical tourism for LASIK surgery is one of the key market trends, Technavio
Published:
2024-03-28
(Crawled : 22:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
Email alert
Add to watchlist
ALC
|
$79.57
-1.47%
0.0%
850K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
one
key
medical
growth
market
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
Published:
2024-03-28
(Crawled : 19:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
AUTL
|
$4.23
-5.58%
-5.91%
2.7M
|
Health Technology
|
Email alert
Add to watchlist
medical
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.